Category archives for: Stocks

PRESIDENT & CFO of Paccar Inc (NASDAQ:PCAR), Schippers Harrie, sells 10,000 shares worth $991,326

According to Paccar Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:07 PM, company PRESIDENT & CFO, Schippers Harrie disclosed selling 10,000 shares at a cost of $99.13. At the time of this transaction (Feb 09), this trade was worth $991,326 in total. As […]

Chief Financial Officer of Transmedics Group, Inc. (NASDAQ:TMDX), Gordon Stephen, sells 10,000 shares worth $250,100

According to Transmedics Group, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:00 PM, company Chief Financial Officer, Gordon Stephen disclosed selling 10,000 shares at a cost of $25.01. At the time of this transaction (Feb 08), this trade was worth $250,100 in total. […]

Director of Penn National Gaming Inc (NASDAQ:PENN), Scaccetti Jane, buys 820 shares worth $99,212

According to Penn National Gaming Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 09:36 PM, company Director, Scaccetti Jane disclosed buying 820 shares at a cost of $120.99. At the time of this transaction (Feb 08), this trade was worth $99,212 in total. As […]

Director of Medallia, Inc. (NYSE:MDLA), Hald Borge, sells 117,000 shares worth $5,303,511

According to Medallia, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 06:59 PM, company Director, Hald Borge disclosed selling 117,000 shares at a cost of $45.33. At the time of this transaction (Feb 09), this trade was worth $5,303,511 in total. As of Feb […]

Director of Community Bankers Trust Corp (NASDAQ:ESXB), Harris Ira C, buys 330 shares worth $2,521

According to Community Bankers Trust Corp’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 09:17 PM, company Director, Harris Ira C disclosed buying 330 shares at a cost of $7.64. At the time of this transaction (Feb 08), this trade was worth $2,521 in total. […]

Director of Medallia, Inc. (NYSE:MDLA), Hald Borge, sells 78,000 shares worth $3,450,008

According to Medallia, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 06:59 PM, company Director, Hald Borge disclosed selling 78,000 shares at a cost of $44.23. At the time of this transaction (Feb 08), this trade was worth $3,450,008 in total. As of Feb […]

Gr Pres Medical and Healthcare of Adtalem Global Education Inc. (NYSE:ATGE), Boden Holland Katherine Alice, buys 611 shares worth $25,016

According to Adtalem Global Education Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 07:46 PM, company Gr Pres Medical and Healthcare, Boden Holland Katherine Alice disclosed buying 611 shares at a cost of $40.94. At the time of this transaction (Feb 10), this trade […]

Director of Transmedics Group, Inc. (NASDAQ:TMDX), Tobin James R, sells 10,168 shares worth $333,786

According to Transmedics Group, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 06:59 PM, company Director, Tobin James R disclosed selling 10,168 shares at a cost of $32.83. At the time of this transaction (Feb 09), this trade was worth $333,786 in total. As […]

10% Owner of Kaleido Biosciences, Inc. (NASDAQ:KLDO), Flagship Ventures Fund Iv Gene, buys 215,000 shares worth $2,472,500

According to Kaleido Biosciences, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 05:30 PM, company 10% Owner, Flagship Ventures Fund Iv Gene disclosed buying 215,000 shares at a cost of $11.50. At the time of this transaction (Feb 08), this trade was worth $2,472,500 […]

SVP, Head of Biology of Ideaya Biosciences, Inc. (NASDAQ:IDYA), Lackner Mark, sells 596 shares worth $12,516

According to Ideaya Biosciences, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 10 06:53 PM, company SVP, Head of Biology, Lackner Mark disclosed selling 596 shares at a cost of $21.00. At the time of this transaction (Feb 10), this trade was worth $12,516 in […]

Featured Press Releases

Photo Gallery

Log in